Financial Incentives for Smoking Cessation
Primary Purpose
Tobacco Use Disorder
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Financial incentives
Sponsored by
About this trial
This is an interventional prevention trial for Tobacco Use Disorder focused on measuring Smoking Cessation, Work-site, Incentives, Cost Effectiveness, Health Behavior, Smoking
Eligibility Criteria
Inclusion Criteria: Employees of General Electric at work sites in the United States Current smokers who report having smoked at least 5 cigarettes per day for the prior 12 months Age 18 or older Exclusion Criteria: Current use of other tobacco products, such as chewing tobacco, pipes, or cigars Planning to leave General Electric within the next 18 months
Sites / Locations
- University of Pennsylvania School of Medicine
Outcomes
Primary Outcome Measures
Biochemically verified smoking cessation rates at 6 months post-quit date
Secondary Outcome Measures
Enrollment in and completion of community-based smoking cessation programs within the first 6 months after randomization
Short-term quit rates at 3 months or 6 months post-quit date
Quit rates at 12 months post-quit date
Full Information
NCT ID
NCT00128375
First Posted
August 8, 2005
Last Updated
December 12, 2007
Sponsor
University of Pennsylvania
Collaborators
Centers for Disease Control and Prevention
1. Study Identification
Unique Protocol Identification Number
NCT00128375
Brief Title
Financial Incentives for Smoking Cessation
Official Title
Financial Incentives for Smoking Cessation
Study Type
Interventional
2. Study Status
Record Verification Date
December 2007
Overall Recruitment Status
Completed
Study Start Date
March 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
April 2008 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
University of Pennsylvania
Collaborators
Centers for Disease Control and Prevention
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to test the effectiveness of financial incentives for increasing long-term smoking cessation rates among employees at General Electric worksites throughout the United States.
Detailed Description
Smoking is the leading cause of preventable mortality in United States, accounting for approximately 435,000 of the 2.4 million deaths each year in the United States. Most smokers make multiple attempts to quit smoking, but only 2-3% succeed each year. Smoking cessation programs have proven effective in helping smokers quit, but only about 5% of smokers enroll in smoking cessation programs each year.
Financial incentives have been shown to increase enrollment in smoking cessation programs and short-term quit rates, but have not been well tested as a mechanism for increasing long-term quit rates. The existing evidence suggests that they could be highly effective, particularly among heavy smokers and low income smokers. In addition, financial incentives for smoking cessation will likely be more cost effective than most covered health services and at least as cost effective as other recommended smoking cessation treatments.
This study is a two-arm randomized clinical trial of financial incentives for smoking cessation among a sample of 850 male and female smokers from GE Energy worksites throughout the U.S. Smokers will be randomized to receive either usual care (information about local community-based smoking cessation resources, coverage of prescription drugs and physician visits) or usual care plus a package of financial incentives that includes $100 for completion of a community-based tobacco cessation program, $250 for short-term smoking cessation at either 3 months or 6 months after randomization, and $400 for smoking cessation 6 months post-quit date (biochemically confirmed).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tobacco Use Disorder
Keywords
Smoking Cessation, Work-site, Incentives, Cost Effectiveness, Health Behavior, Smoking
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
878 (false)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
Financial incentives
Primary Outcome Measure Information:
Title
Biochemically verified smoking cessation rates at 6 months post-quit date
Secondary Outcome Measure Information:
Title
Enrollment in and completion of community-based smoking cessation programs within the first 6 months after randomization
Title
Short-term quit rates at 3 months or 6 months post-quit date
Title
Quit rates at 12 months post-quit date
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Employees of General Electric at work sites in the United States
Current smokers who report having smoked at least 5 cigarettes per day for the prior 12 months
Age 18 or older
Exclusion Criteria:
Current use of other tobacco products, such as chewing tobacco, pipes, or cigars
Planning to leave General Electric within the next 18 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kevin G Volpp, MD, PhD
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pennsylvania School of Medicine
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104-6021
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
19213683
Citation
Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, Galvin R, Zhu J, Wan F, DeGuzman J, Corbett E, Weiner J, Audrain-McGovern J. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009 Feb 12;360(7):699-709. doi: 10.1056/NEJMsa0806819.
Results Reference
derived
Learn more about this trial
Financial Incentives for Smoking Cessation
We'll reach out to this number within 24 hrs